Hi-Acts as multiplier: Opening of the HZDR transfer exhibition

The permanent exhibition, co-financed by Hi-Acts was opened as part of the HZDR Transfer Day by Prof Sebastian M. Schmidt, Scientific Director of the HZDR, and Dr Björn Wolf, Head of the Technology Transfer and Innovation Department. In the presence of more than 80 employees of the HZDR and guests from other Helmholtz centres as well as network partners, the radiance and the outgoing innovation impulses were visualised in a particularly vivid way.

Among them, of course, Hi-Acts. Because some of the areas of transfer-relevant research at the HZDR work with particle accelerators. The centre has several accelerator facilities, which are also available for use by other research institutions or business partners. Ion implantation is a particular success here. Since 2012, it has been commercialised via HZDR Innovation. And with great success: HZDR Innovation GmbH, partner in the Hi-Acts network, is the European market leader in ion implantation.

The HZDR also makes a significant contribution to Dresden as a centre of business and research in the field of medical radionuclide production. Together with many partners, including ROTOP Pharmaka GmbH, innovative new approaches for cancer therapies and the efficiency of diagnostic and therapeutic radiopharmaceuticals are being researched AND produced. This recently led to another major transfer success: the Saxon Radiopharmacy Network nukliD® was founded at the end of January 2025.

Link to the article HZDR Transfer Day: https://www.hzdr.de/db/Cms?pOid=74078&pNid=3438